Takahashi H , Tsukada T , Tatewaki W , Hanano M , Sanada M , Shibata A . Von Willebrand factor fragment in type IIB von Willebrand's disease: demonstration of two different forms of fragments . Haemostasis1987; 17: 182–188 .
2.
Matsuura E , Igarashi Y , Fujimoto M et al. Anticardiolipin antibodies recognize b2-glycoprotein I .structure altered by interacting with an oxygen modified solid phase surface. J Exp Med1994; 179: 457–462 .
3.
Galli M , Barbui T . Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome . Blood1999; 93: 2149–2157 .
4.
Diez-Ewald M , Torres-Guerra E , Vizcaino G , Arteaga-Vizcaino M . Platelet function in patients with lupus anticoagulant and thrombosis . Invest Clin1995; 36: 13–21 .
5.
Schinco P , Borchiellini A , Tamponi G et al. Lupus anticoagulant and thrombosis: role of von Willebrand factor multimeric forms . Clin Exp Rheumatol1997; 15: 5–10 .
6.
Furlan M , Robles R , Galbusera M et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome . New Engl J Med1998; 339: 1578–1584 .
7.
Tsai H-M , Lian EC-Y . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura . New Engl J Med1998; 339: 1585–1594 .
8.
Asherson RA , Cervera R , Piette J-C et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients . Medicine1998; 77: 195–207 .